Home/ Supplements/ Omega 3/ Availom High DHA Algae Powder

Availom High DHA Algae Powder

product on market Powder Nootropics Depot Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product provides omega-3 fatty acids, specifically DHA, which are supported by strong evidence for maintaining cognitive function and cardiovascular health. These polyunsaturated fats serve as essential nutrients that the body cannot produce independently. Research indicates a high safety profile for algae-based omega-3 supplementation in general populations.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Availom High DHA Algae Powder
Open Full PDF View on NIH DSLD →
Details

Label Data

400 mg
Serving Size
150
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Fat
272 mg (1% DV)
Polyunsaturated Fat
259 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

L-Lysine
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 400mg daily.

Warnings & Precautions

Disclaimer: Always consult with a qualified health physician before taking any new dietary supplement.

Warning: People with seafood allergies, coagulopathy or taking anticoagulants should consult with their physician prior to taking dietary supplements.

Warning: People with seafood allergies, coagulopathy or taking anticoagulants should consult with their physician prior to taking dietary supplements.

Keep out of reach of children. Do not take this or any supplement if under 18, pregnant or nursing, if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

Do not take this or any supplement if under 18, pregnant or nursing, if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

Formulation Notes

DHA 48% / EPA 1%

Additional Information

Storage: Store in a cool and dry place. Keep away from direct sunlight and heat.

Metadata

Product Details

DSLD Entry Date2023-05-24
Product TypeFat/Fatty Acid
FormPowder
DSLD ID285685
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.